Mounjaro is being introduced gradually across the NHS and is currently only available to a small number of patients who meet strict clinical criteria following a clinical assessment. There’s no need to contact the practice – if you are eligible, your GP practice or the NHS will contact you directly. Due to the way the treatment is being phased in, this may take a little time.
In the first year, Mounjaro is only available to patients who have:
- A BMI of 40 or more (adjusted for ethnicity)
- At least 4 of the following health conditions:
- type 2 diabetes
- high blood pressure
- heart disease
- obstructive sleep apnoea
- abnormal blood fats (dyslipidemias)
- Or where urgent weight loss is needed for critical surgery or treatment
If you’re from a South Asian, Chinese, Middle Eastern, Black African or African-Caribbean background, the BMI threshold is slightly lower – 37.5 instead of 40.
Leeds specific information
West Yorkshire ICB is currently reviewing its commissioning policy/statement for provision for weight management drugs plus non-drug pathways; with consideration of service capacity/resources, etc. A decision is likely to be made towards the end of July.
The NHS is introducing this treatment in stages based on funding and capacity, which means some people who meet national clinical guidance (NICE) may not yet be eligible under local NHS rules.
Please know this is not about you. It’s about how services are being phased. You are still entitled to care, and we will work with you to explore other options for support – which may include help with emotional wellbeing, physical activity, peer groups, or community resources.
Other Weight Loss support available: